What are 3D drug-eluting balloons (DEBs)?

3D drug-eluting balloons are medical devices used to deliver drugs directly to targeted areas in the body, primarily to treat cardiovascular diseases.

Who are the key companies/players in the 3D Drug Eluting Balloons Applications in Healthcare Market?

Some of the key players in the 3D Drug Eluting Balloons Applications in Healthcare Markets are Hewlett Packard, Medical Molding inc, Proto Labs, 3D Systems, Stratasys, SLM Solutions, Nano Dimension, ExOne

They release medication from the balloon surface into the arterial walls during angioplasty, reducing the risk of restenosis and promoting better patient outcomes.

Which end-users dominate the market?

Medical and surgical centers dominate, accounting for 54% of the market share, followed by pharmaceutical and biotechnology companies, and academic institutions.

Why is North America a significant market for 3D DEBs?

North America holds a 41.6% market share due to advanced healthcare infrastructure, high adoption rates of new technologies, and substantial R&D investments.